BioCentury
ARTICLE | Company News

United Therapeutics panel set for February

December 1, 2000 8:00 AM UTC

The FDA's Cardiovascular and Renal Drugs Advisory Committee will review on Feb. 9 UTHR's NDA for its Uniprost ( UT-15) modified prostacyclin to treat pulmonary arterial hypertension. Panel review of U...